Olivier Gouédard

Director de Operaciones en Cytovia Therapeutics, Inc. .

Consumer Services

Health Technology

Perfil

Olivier Gouédard is currently the Chief Operating Officer at Cytovia Therapeutics, Inc. He holds an MBA from New York University, a doctorate from the University of Rennes, and an undergraduate degree from Université Paris-Saclay.

Cargos activos de Olivier Gouédard

Empresas	Cargo	Inicio
Cytovia Therapeutics, Inc. Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.	Director de Operaciones	22/06/2021

Todos los cargos activos de Olivier Gouédard

Formación de Olivier Gouédard.

New York University	Masters Business Admin
Université Paris-Saclay	Undergraduate Degree
University of Rennes	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Olivier Gouédard.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Cytovia Therapeutics, Inc. Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.	Health Technology